250 related articles for article (PubMed ID: 23826311)
1. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.
Neuhaus J; Schiffer E; von Wilcke P; Bauer HW; Leung H; Siwy J; Ulrici W; Paasch U; Horn LC; Stolzenburg JU
PLoS One; 2013; 8(6):e67514. PubMed ID: 23826311
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
[TBL] [Abstract][Full Text] [Related]
3. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
5. Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7.
Falegan OS; Jarvi K; Vogel HJ; Hyndman ME
Prostate; 2021 Aug; 81(11):713-720. PubMed ID: 34097313
[TBL] [Abstract][Full Text] [Related]
6. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
Li C; Zang T; Wrobel K; Huang JT; Nabi G
Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
[TBL] [Abstract][Full Text] [Related]
9. Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.
Kawahara R; Recuero S; Nogueira FCS; Domont GB; Leite KRM; Srougi M; Thaysen-Andersen M; Palmisano G
Proteomics; 2019 Nov; 19(21-22):e1900174. PubMed ID: 31576646
[TBL] [Abstract][Full Text] [Related]
10. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
11. [Proteome-based diagnostic and prognostic biomarkers of prostate cancer].
Neuhaus J; Schiffer E; Siwy J; Mannello F; Horn LC; Stolzenburg JU
Urologe A; 2013 Sep; 52(9):1251-5. PubMed ID: 24026060
[TBL] [Abstract][Full Text] [Related]
12. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
13. Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study.
Neuhaus J; Schiffer E; Mannello F; Horn LC; Ganzer R; Stolzenburg JU
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28471417
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of prostate cancer by analyzing oxidative stress in human seminal plasma: developing unsophisticated tools for noninvasive prostate cancer diagnosis.
Barrio-Muñoz M; Abad-Gairín C; Amengual-Guedán JM; Prats-López J
Eur J Cancer Prev; 2016 Nov; 25(6):518-23. PubMed ID: 26633164
[TBL] [Abstract][Full Text] [Related]
15. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach.
Rolland AD; Lavigne R; Dauly C; Calvel P; Kervarrec C; Freour T; Evrard B; Rioux-Leclercq N; Auger J; Pineau C
Hum Reprod; 2013 Jan; 28(1):199-209. PubMed ID: 23024119
[TBL] [Abstract][Full Text] [Related]
16. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
[TBL] [Abstract][Full Text] [Related]
17. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
18. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.
Mao C; Ding Y; Xu N
Mol Cell Biochem; 2022 Jan; 477(1):213-223. PubMed ID: 34655417
[TBL] [Abstract][Full Text] [Related]
19. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
[TBL] [Abstract][Full Text] [Related]
20. sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.
Tsaur I; Thurn K; Juengel E; Gust KM; Borgmann H; Mager R; Bartsch G; Oppermann E; Ackermann H; Nelson K; Haferkamp A; Blaheta RA
J Exp Clin Cancer Res; 2015 May; 34(1):43. PubMed ID: 25967040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
